Webinar: Comparing Biomarkers Used in Sepsis

sepsis-webinar-infographic

Event Details

Originally Aired: September 13, 2016

Time: 2:00 PM EDT

Presenter: Mike Broyles, BSPharm, PharmD

Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.

Comparing Biomarkers Used in Infection, Sepsis and Septic Shock: What is the Role of Procalcitonin?

Fisher HealthCare presents a complimentary, PACE-accredited webinar that will help attendees determine which marker or group of markers can provide clinicians with effective clinical information both upon presentation and during the course of treatment of the septic patient.

Sepsis is the sixth most common principal diagnosis affecting one out of every 23 inpatients. The in-hospital mortality rate due to sepsis is 16%, which is nearly eight times higher than the average inpatient mortality rate.

The impact of sepsis on hospitals includes:

  • A higher-than-normal mortality rate, which adversely affects clinical outcomes
  • Septicemia is the second-highest 30-day Medicare readmission diagnosis, resulting in 92,900 readmissions annually
  • Sepsis is the most expensive inpatient diagnosis with over $23B in aggregate hospital costs, accounting for 5.2% of all costs but only 2.8% of discharges

Learning Objectives:

  • Attendees will be able to assess if their current biomarker choices provide their clinicians with optimal clinical effectiveness 
  • Participants will understand how procalcitonin (PCT), a biomarker of the host response to a systemic bacterial infection, can provide rapid insight into the risk of progression to sepsis and mortality risk 
  • Review currently available biomarkers used for the diagnosis and treatment of infectious disease, sepsis and septic shock
  • Compare and contrast common biomarkers to determine which marker or group of markers can provide clinicians with the most effective clinical information
  • Case Study: Five Rivers Medical Center pre- and post-procalcitonin implementation

Watch On Demand      View Slides

mike-broyles

Presenter

Mike Broyles, BSPharm, PharmD

Director of Pharmacy and Laboratory Services Five Rivers Medical Center, Arkansas

Mike Broyles is a Doctorate-Prepared Pharmacist with 25 years of experience as a Hospital Pharmacy Director providing patients with current concepts in the clinical use of drugs.   Working for a large IDN as their pharmacy advisory chairman to develop and implement clinical initiatives, he additionally consults for several IDN’s, Alaris, Cardinal Health, Carefusion, bioMerieux, ICNet, and independently serves hospitals from 35 to 1,200 beds in size. Dr. Broyles' projects include TheraTrac 2, Stellara, ABX Alert, TheraDoc, coagulation, sepsis management, and antimicrobial stewardship programs, including those using the biomarker procalcitonin to reduce antimicrobial exposure. His goal is to provide the leading thought processes in patient management and use technology to enhance the ability of clinicians to have the best options in a patient’s clinical status, decision support and documentation to improve outcomes.